Disclosure of grounds of European withdrawn and refused applications: a step forward on regulatory transparency

Br J Clin Pharmacol. 2013 Apr;75(4):1149-51. doi: 10.1111/j.1365-2125.2012.04424.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Disclosure / legislation & jurisprudence*
  • Drug Approval / legislation & jurisprudence*
  • European Union*
  • Humans